BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 4, 2005
View Archived Issues
Alkermes' Alcohol Dependence Drug Vivitrex On File With FDA
Alkermes Inc. applied for FDA approval of Vivitrex (naltrexone long-acting injection) to treat alcoholism, making it the first injectable product filed for the indication. (BioWorld Today)
Read More
Progenics Raising $30M For MNTX, HIV, Cancer Programs
Read More
Cephalon Files For Approval Of Next Generation Provigil
Read More
Exelixis Drops Ag Joint Venture, Gets $21M To Focus On Pipeline
Read More
Other News To Note
Read More